The company announced a change to its Board of Directors. Christopher Bull resigned as a director of the company effective December 1, 2025, and the resulting vacancy has been filled by the appointment of Graham Patrick.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PBM:
- Psyence Biomedical announces approval for use of PsyLab’s psilocybin product
- Psyence Biomedical CEO says 2025 was a ‘turning point’ for company
- Psyence Biomedical announces psilocybin longevity research program
- Psyence BioMed Expands Ibogaine Operations in Africa with Strategic Investment
- Psyence Biomedical Reports Strong Financial Growth in Latest Interim Results